Paying user area
Try for free
Johnson & Johnson pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Geographic Areas
- Enterprise Value to FCFF (EV/FCFF)
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Johnson & Johnson for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
---|---|---|---|---|---|
Dec 29, 2024 | = | ÷ | |||
Dec 31, 2023 | = | ÷ | |||
Dec 31, 2022 | = | ÷ | |||
Dec 31, 2021 | = | ÷ | |||
Dec 31, 2020 | = | ÷ | |||
Dec 29, 2019 | = | ÷ | |||
Dec 30, 2018 | = | ÷ | |||
Dec 31, 2017 | = | ÷ | |||
Dec 31, 2016 | = | ÷ | |||
Dec 31, 2015 | = | ÷ | |||
Dec 28, 2014 | = | ÷ | |||
Dec 29, 2013 | = | ÷ | |||
Dec 30, 2012 | = | ÷ | |||
Dec 31, 2011 | = | ÷ | |||
Dec 31, 2010 | = | ÷ | |||
Dec 31, 2009 | = | ÷ | |||
Dec 28, 2008 | = | ÷ | |||
Dec 30, 2007 | = | ÷ | |||
Dec 31, 2006 | = | ÷ | |||
Dec 31, 2005 | = | ÷ |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The financial data reveals several notable trends in the liquidity position over the analyzed periods. The current assets demonstrate variability, with an initial decline from 31,394 million USD at the end of 2005 to a low of 22,975 million USD in 2006, followed by a general upward movement until 2011, peaking at 54,316 million USD. However, a sharp decrease is observed in 2017, where current assets dropped to 43,088 million USD from 65,032 million USD in 2016. After this dip, the assets once again exhibit a rising trend up to 2021, reaching 60,979 million USD, before fluctuating downward through 2024.
Current liabilities present a general upward trajectory throughout the years, starting at 12,635 million USD in 2005 and escalating consistently to reach a peak of 55,802 million USD in 2022. Minor declines appear in 2014 and 2016, but these are temporary as the overall trend remains increasing, indicative of growing obligations over time.
The current ratio, which reflects liquidity by comparing current assets to current liabilities, shows significant fluctuations and an overall declining tendency in recent years. Initially, the ratio is relatively high at 2.48 in 2005, followed by a steep drop to 1.2 in 2006. From then, it gradually recovers to a high of 2.47 in 2016. Post-2016, there is a marked decline, falling below the critical threshold of 1 in 2022 (0.99), before modestly increasing again but remaining near or just above 1 through 2024. This pattern suggests a weakening short-term liquidity position towards the latter part of the period.
- Current Assets
- Exhibit an overall increasing trend from 2006 to 2011, a sharp decline in 2017, followed by recovery and fluctuation through 2024.
- Current Liabilities
- Show a consistent upward trend across the entire period, indicating rising short-term obligations.
- Current Ratio
- Starts high, falls sharply in 2006, recovers until 2016, then declines again, dipping below 1 in 2022, signaling potential liquidity challenges in recent years.
Comparison to Competitors
Johnson & Johnson | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 29, 2024 | ||||||||||||
Dec 31, 2023 | ||||||||||||
Dec 31, 2022 | ||||||||||||
Dec 31, 2021 | ||||||||||||
Dec 31, 2020 | ||||||||||||
Dec 29, 2019 | ||||||||||||
Dec 30, 2018 | ||||||||||||
Dec 31, 2017 | ||||||||||||
Dec 31, 2016 | ||||||||||||
Dec 31, 2015 | ||||||||||||
Dec 28, 2014 | ||||||||||||
Dec 29, 2013 | ||||||||||||
Dec 30, 2012 | ||||||||||||
Dec 31, 2011 | ||||||||||||
Dec 31, 2010 | ||||||||||||
Dec 31, 2009 | ||||||||||||
Dec 28, 2008 | ||||||||||||
Dec 30, 2007 | ||||||||||||
Dec 31, 2006 | ||||||||||||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Johnson & Johnson, current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Johnson & Johnson | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 29, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 29, 2019 | ||
Dec 30, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 28, 2014 | ||
Dec 29, 2013 | ||
Dec 30, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 28, 2008 | ||
Dec 30, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Johnson & Johnson | Health Care | |
---|---|---|
Dec 29, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 29, 2019 | ||
Dec 30, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 28, 2014 | ||
Dec 29, 2013 | ||
Dec 30, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 28, 2008 | ||
Dec 30, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).